Abstract

Mutations in the chloride channel cystic fibrosis transmembrane regulator (CFTR) cause cystic fibrosis, a genetic disorder characterized by defects in CFTR biosynthesis, localization to the cell surface, or activation by regulatory factors. It was discovered recently that surface localization of CFTR is stabilized by an interaction between the CFTR N terminus and the multidomain cytoskeletal protein filamin. The details of the CFTR-filamin interaction, however, are unclear. Using x-ray crystallography, we show how the CFTR N terminus binds to immunoglobulin-like repeat 21 of filamin A (FlnA-Ig21). CFTR binds to beta-strands C and D of FlnA-Ig21 using backbone-backbone hydrogen bonds, a linchpin serine residue, and hydrophobic side-chain packing. We use NMR to determine that the CFTR N terminus also binds to several other immunoglobulin-like repeats from filamin A in vitro. Our structural data explain why the cystic fibrosis-causing S13F mutation disrupts CFTR-filamin interaction. We show that FlnA-Ig repeats transfected into cultured Calu-3 cells disrupt CFTR-filamin interaction and reduce surface levels of CFTR. Our findings suggest that filamin A stabilizes surface CFTR by anchoring it to the actin cytoskeleton through interactions with multiple filamin Ig repeats. Such an interaction mode may allow filamins to cluster multiple CFTR molecules and to promote colocalization of CFTR and other filamin-binding proteins in the apical plasma membrane of epithelial cells.

Highlights

  • Mutations in the chloride channel cystic fibrosis transmembrane regulator (CFTR) cause cystic fibrosis, a genetic disorder characterized by defects in CFTR biosynthesis, localization to the cell surface, or activation by regulatory factors

  • S13F-CFTR, which is unable to bind to filamins, exhibits reduced surface levels compared with wild-type CFTR

  • CFTR surface levels are suppressed in cells transfected with peptides that mimic the CFTR N terminus and ostensibly displace native CFTR from filamins [15]

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Anti-human CFTR (C terminus-specific) monoclonal antibody was obtained from R&D Systems. Crystal Structure Determination of FlnA-Ig211⁄7CFTR4–22 Complex—Crystallization was carried out using 1 mM FlnAIg21 in 20 mM Tris, pH 7.4, 50 mM NaCl, mixed with 3 mM CFTR4 –22 peptide (SPLEKASVVSKLFFSWTRP) in water. Diffraction data were collected at Advanced Light Source beamline 4.2.2., Lawrence Berkeley National Laboratory. Diffraction from these crystals was typically very anisotropic. The FlnA-Ig21 monomer structure and a polyalanine model of the integrin ␤7 C terminus (Protein Data Bank (PDB) code 2BRQ) (Ref. 23) were used as search models. Data collection Beamline Wavelength (Å) Space group Cell dimensions a, b, c (Å) ␣, ␤, ␥ (degree) Resolution range (Å) Rsym (%) I/␴I Completeness (%) Redundancy.

90 Ϯ 9 315 Ϯ 22 135 Ϯ 8 127 Ϯ 9
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call